- Aardvark's next move after clinical hold; Alumis' verdict on Acelyrin assetPlus, news about Tenaya’s TN-401 and Taiho’s Inqovi. 📉 Aardvark to unblind rare disease trial following clinical hold: The FDA has placed a full clinical hold on the company's candidate for ...Endpoints · 2mo ago↗ source
- India’s pharma industry is going global. But can it catch up to China?A record Sun Pharma acquisition signals global ambitions. But infrastructure, capital and policy gaps could stand in the way of India becoming an R&D powerhouse.BioPharma Dive · 2mo ago↗ source
- OncLive Polls Reveal Picks for Top GI Cancer Abstracts, Areas of Interest at ASCO 2026Polls highlighted key abstracts of interest from the upcoming ASCO Annual Meeting.onclive · 2mo ago